Literature DB >> 16181679

Thirteen years of culture-positive M. bovis-BCG infection in an IL-12Rbeta1 deficient patient: treatment and outcome.

S D Rosenzweig1, J Yancoski, A Bernasconi, S Krasovec, B E Marciano, L Casimir, G Berberian, N Símboli, M Rousseau, G Calle.   

Abstract

Patients with mutations in the IFNgamma/IL-12 pathway show an exquisite susceptibility to mycobacterial diseases. An IL-12Rbeta1 deficient patient with impaired intestinal absorption suffered from a 13 year culture-positive Mycobacterium bovis-BCG infection with acquired multidrug resistance. A combined parenteral and enteral anti-mycobacterial treatment, including recombinant IFNgamma, helped to clear his infection.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16181679     DOI： 10.1016/j.jinf.2005.07.009

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  7 in total

Review 1.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Authors:  Sayna Norouzi; Asghar Aghamohammadi; Setareh Mamishi; Sergio D Rosenzweig; Nima Rezaei
Journal:  J Infect       Date:  2012-03-16       Impact factor: 6.072

2.  Mycobacterium bovis BCG-itis and cervical lymphadenitis due to Salmonella enteritidis in a patient with complete interleukin-12/-23 receptor beta1 deficiency.

Authors:  E van de Vosse; T H M Ottenhoff; R A de Paus; E M Verhard; T de Boer; J T van Dissel; T W Kuijpers
Journal:  Infection       Date:  2010-03-05       Impact factor: 3.553

Review 3.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

Review 4.  IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database.

Authors:  Esther van de Vosse; Margje H Haverkamp; Noe Ramirez-Alejo; Mónica Martinez-Gallo; Lizbeth Blancas-Galicia; Ayşe Metin; Ben Zion Garty; Çağman Sun-Tan; Arnon Broides; Roelof A de Paus; Özlem Keskin; Deniz Çağdaş; Ilhan Tezcan; Encarna Lopez-Ruzafa; Juan I Aróstegui; Jacov Levy; Francisco J Espinosa-Rosales; Özden Sanal; Leopoldo Santos-Argumedo; Jean-Laurent Casanova; Stephanie Boisson-Dupuis; Jaap T van Dissel; Jacinta Bustamante
Journal:  Hum Mutat       Date:  2013-08-08       Impact factor: 4.878

5.  A 475 years-old founder effect involving IL12RB1: a highly prevalent mutation conferring Mendelian Susceptibility to Mycobacterial Diseases in European descendants.

Authors:  J Yancoski; C Rocco; A Bernasconi; M Oleastro; L Bezrodnik; C Vrátnica; F Haerynck; S D Rosenzweig
Journal:  Infect Genet Evol       Date:  2009-03-09       Impact factor: 3.342

6.  Treatment of disseminated mycobacterial infection with high-dose IFN-γ in a patient with IL-12Rβ1 deficiency.

Authors:  Abdullah A Alangari; Fahad Al-Zamil; Abdulrahman Al-Mazrou; Saleh Al-Muhsen; Stéphanie Boisson-Dupuis; Sitalbanat Awadallah; Abdelmageed Kambal; Jean-Laurent Casanova
Journal:  Clin Dev Immunol       Date:  2010-12-22

7.  Chronic Disseminated Salmonellosis in a Patient With Interleukin-12p40 Deficiency.

Authors:  Emadia Mohammad Alaki; Fahad Aljobair; Faisal Alaklobi; Mobarak Al Shamrani; Fahad Al-Zahim; Aziza Dongues; Jean-Laurent Casanova
Journal:  Pediatr Infect Dis J       Date:  2018-01       Impact factor: 2.129
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.